nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—Gilles de la Tourette syndrome—Clonidine—glaucoma	0.534	1	CpDpCtD
Haloperidol—CYP1A1—Clonidine—glaucoma	0.0233	0.0848	CbGbCtD
Haloperidol—CYP2D6—Carteolol—glaucoma	0.0232	0.0843	CbGbCtD
Haloperidol—CYP1A2—Betaxolol—glaucoma	0.019	0.0691	CbGbCtD
Haloperidol—CYP2D6—Betaxolol—glaucoma	0.0157	0.057	CbGbCtD
Haloperidol—CYP2C19—Methazolamide—glaucoma	0.0156	0.0568	CbGbCtD
Haloperidol—CYP2C9—Diclofenamide—glaucoma	0.0151	0.0549	CbGbCtD
Haloperidol—CYP2C9—Dorzolamide—glaucoma	0.0146	0.053	CbGbCtD
Haloperidol—CYP3A5—Clonidine—glaucoma	0.014	0.0509	CbGbCtD
Haloperidol—CYP2C19—Timolol—glaucoma	0.0133	0.0483	CbGbCtD
Haloperidol—CYP2C9—Methazolamide—glaucoma	0.013	0.0472	CbGbCtD
Haloperidol—CYP2D6—Methazolamide—glaucoma	0.0119	0.0432	CbGbCtD
Haloperidol—CYP3A4—Pilocarpine—glaucoma	0.0112	0.0406	CbGbCtD
Haloperidol—ABCB1—Timolol—glaucoma	0.0107	0.039	CbGbCtD
Haloperidol—CYP1A2—Clonidine—glaucoma	0.0104	0.0379	CbGbCtD
Haloperidol—CYP2D6—Timolol—glaucoma	0.0101	0.0367	CbGbCtD
Haloperidol—ABCB1—Clonidine—glaucoma	0.00912	0.0331	CbGbCtD
Haloperidol—CYP3A4—Brinzolamide—glaucoma	0.00878	0.0319	CbGbCtD
Haloperidol—CYP2D6—Clonidine—glaucoma	0.00859	0.0312	CbGbCtD
Haloperidol—CYP3A4—Dorzolamide—glaucoma	0.00848	0.0308	CbGbCtD
Haloperidol—CYP3A4—Methazolamide—glaucoma	0.00755	0.0275	CbGbCtD
Haloperidol—CYP3A4—Acetazolamide—glaucoma	0.00604	0.0219	CbGbCtD
Haloperidol—CYP3A4—Clonidine—glaucoma	0.00546	0.0199	CbGbCtD
Haloperidol—CBR1—Treprostinil—Latanoprost—glaucoma	0.00128	0.595	CbGdCrCtD
Haloperidol—EBP—Treprostinil—Latanoprost—glaucoma	0.000873	0.405	CbGdCrCtD
Haloperidol—Agranulocytosis—Betaxolol—glaucoma	0.00016	0.00113	CcSEcCtD
Haloperidol—Dermatitis—Latanoprost—glaucoma	0.00016	0.00113	CcSEcCtD
Haloperidol—Dyspepsia—Acetazolamide—glaucoma	0.00016	0.00113	CcSEcCtD
Haloperidol—Tachycardia—Brinzolamide—glaucoma	0.000159	0.00113	CcSEcCtD
Haloperidol—Mediastinal disorder—Clonidine—glaucoma	0.000159	0.00113	CcSEcCtD
Haloperidol—Headache—Latanoprost—glaucoma	0.000159	0.00113	CcSEcCtD
Haloperidol—Skin disorder—Brinzolamide—glaucoma	0.000159	0.00113	CcSEcCtD
Haloperidol—Anorexia—Dorzolamide—glaucoma	0.000158	0.00112	CcSEcCtD
Haloperidol—Confusional state—Pilocarpine—glaucoma	0.000158	0.00112	CcSEcCtD
Haloperidol—Decreased appetite—Acetazolamide—glaucoma	0.000158	0.00112	CcSEcCtD
Haloperidol—Insomnia—Brimonidine—glaucoma	0.000157	0.00112	CcSEcCtD
Haloperidol—Oedema—Pilocarpine—glaucoma	0.000157	0.00111	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000157	0.00111	CcSEcCtD
Haloperidol—Alopecia—Clonidine—glaucoma	0.000156	0.00111	CcSEcCtD
Haloperidol—Nausea—Methazolamide—glaucoma	0.000156	0.0011	CcSEcCtD
Haloperidol—Hypotension—Dorzolamide—glaucoma	0.000155	0.0011	CcSEcCtD
Haloperidol—Dyspnoea—Brimonidine—glaucoma	0.000155	0.0011	CcSEcCtD
Haloperidol—Somnolence—Brimonidine—glaucoma	0.000155	0.0011	CcSEcCtD
Haloperidol—Mental disorder—Clonidine—glaucoma	0.000155	0.0011	CcSEcCtD
Haloperidol—Hypotension—Travoprost—glaucoma	0.000155	0.0011	CcSEcCtD
Haloperidol—Bronchospasm—Timolol—glaucoma	0.000154	0.00109	CcSEcCtD
Haloperidol—Thrombocytopenia—Pilocarpine—glaucoma	0.000154	0.00109	CcSEcCtD
Haloperidol—Tachycardia—Pilocarpine—glaucoma	0.000153	0.00109	CcSEcCtD
Haloperidol—Dyspepsia—Brimonidine—glaucoma	0.000153	0.00109	CcSEcCtD
Haloperidol—Hallucination—Betaxolol—glaucoma	0.000153	0.00108	CcSEcCtD
Haloperidol—Hypotension—Brinzolamide—glaucoma	0.000153	0.00108	CcSEcCtD
Haloperidol—Hyperhidrosis—Pilocarpine—glaucoma	0.000152	0.00108	CcSEcCtD
Haloperidol—Insomnia—Dorzolamide—glaucoma	0.00015	0.00107	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Brimonidine—glaucoma	0.00015	0.00107	CcSEcCtD
Haloperidol—Anorexia—Pilocarpine—glaucoma	0.00015	0.00106	CcSEcCtD
Haloperidol—Feeling abnormal—Acetazolamide—glaucoma	0.000149	0.00106	CcSEcCtD
Haloperidol—Hypersensitivity—Apraclonidine—glaucoma	0.000149	0.00106	CcSEcCtD
Haloperidol—Dyspnoea—Dorzolamide—glaucoma	0.000148	0.00105	CcSEcCtD
Haloperidol—Visual impairment—Betaxolol—glaucoma	0.000148	0.00105	CcSEcCtD
Haloperidol—Insomnia—Brinzolamide—glaucoma	0.000148	0.00105	CcSEcCtD
Haloperidol—Somnolence—Dorzolamide—glaucoma	0.000148	0.00105	CcSEcCtD
Haloperidol—Muscle spasms—Clonidine—glaucoma	0.000148	0.00105	CcSEcCtD
Haloperidol—Dyspnoea—Travoprost—glaucoma	0.000148	0.00105	CcSEcCtD
Haloperidol—Hypotension—Pilocarpine—glaucoma	0.000147	0.00104	CcSEcCtD
Haloperidol—Dyspepsia—Dorzolamide—glaucoma	0.000146	0.00104	CcSEcCtD
Haloperidol—Dyspnoea—Brinzolamide—glaucoma	0.000146	0.00103	CcSEcCtD
Haloperidol—Dyspepsia—Travoprost—glaucoma	0.000146	0.00103	CcSEcCtD
Haloperidol—Somnolence—Brinzolamide—glaucoma	0.000145	0.00103	CcSEcCtD
Haloperidol—Vision blurred—Clonidine—glaucoma	0.000145	0.00103	CcSEcCtD
Haloperidol—Decreased appetite—Dorzolamide—glaucoma	0.000144	0.00102	CcSEcCtD
Haloperidol—Erectile dysfunction—Timolol—glaucoma	0.000144	0.00102	CcSEcCtD
Haloperidol—Urticaria—Acetazolamide—glaucoma	0.000144	0.00102	CcSEcCtD
Haloperidol—Tremor—Clonidine—glaucoma	0.000144	0.00102	CcSEcCtD
Haloperidol—Dyspepsia—Brinzolamide—glaucoma	0.000144	0.00102	CcSEcCtD
Haloperidol—Eye disorder—Betaxolol—glaucoma	0.000144	0.00102	CcSEcCtD
Haloperidol—Pruritus—Apraclonidine—glaucoma	0.000143	0.00102	CcSEcCtD
Haloperidol—Body temperature increased—Acetazolamide—glaucoma	0.000143	0.00102	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Travoprost—glaucoma	0.000143	0.00101	CcSEcCtD
Haloperidol—Cardiac disorder—Betaxolol—glaucoma	0.000143	0.00101	CcSEcCtD
Haloperidol—Insomnia—Pilocarpine—glaucoma	0.000142	0.00101	CcSEcCtD
Haloperidol—Decreased appetite—Brinzolamide—glaucoma	0.000142	0.00101	CcSEcCtD
Haloperidol—Weight decreased—Timolol—glaucoma	0.000142	0.00101	CcSEcCtD
Haloperidol—Constipation—Travoprost—glaucoma	0.000141	0.001	CcSEcCtD
Haloperidol—Hyperglycaemia—Timolol—glaucoma	0.000141	0.001	CcSEcCtD
Haloperidol—Agitation—Clonidine—glaucoma	0.000141	0.001	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000141	0.001	CcSEcCtD
Haloperidol—Dyspnoea—Pilocarpine—glaucoma	0.00014	0.000993	CcSEcCtD
Haloperidol—Somnolence—Pilocarpine—glaucoma	0.00014	0.00099	CcSEcCtD
Haloperidol—Depression—Timolol—glaucoma	0.000139	0.000989	CcSEcCtD
Haloperidol—Angiopathy—Betaxolol—glaucoma	0.000139	0.000989	CcSEcCtD
Haloperidol—Pruritus—Bimatoprost—glaucoma	0.000139	0.000986	CcSEcCtD
Haloperidol—Immune system disorder—Betaxolol—glaucoma	0.000139	0.000984	CcSEcCtD
Haloperidol—Diarrhoea—Apraclonidine—glaucoma	0.000139	0.000983	CcSEcCtD
Haloperidol—Mediastinal disorder—Betaxolol—glaucoma	0.000138	0.000982	CcSEcCtD
Haloperidol—Dyspepsia—Pilocarpine—glaucoma	0.000138	0.00098	CcSEcCtD
Haloperidol—Feeling abnormal—Dorzolamide—glaucoma	0.000137	0.000971	CcSEcCtD
Haloperidol—Decreased appetite—Pilocarpine—glaucoma	0.000136	0.000968	CcSEcCtD
Haloperidol—Feeling abnormal—Travoprost—glaucoma	0.000136	0.000967	CcSEcCtD
Haloperidol—Alopecia—Betaxolol—glaucoma	0.000136	0.000963	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000136	0.000961	CcSEcCtD
Haloperidol—Feeling abnormal—Brinzolamide—glaucoma	0.000135	0.000955	CcSEcCtD
Haloperidol—Mental disorder—Betaxolol—glaucoma	0.000135	0.000955	CcSEcCtD
Haloperidol—Constipation—Pilocarpine—glaucoma	0.000134	0.000952	CcSEcCtD
Haloperidol—Dizziness—Apraclonidine—glaucoma	0.000134	0.00095	CcSEcCtD
Haloperidol—Malnutrition—Betaxolol—glaucoma	0.000134	0.000949	CcSEcCtD
Haloperidol—Urticaria—Dorzolamide—glaucoma	0.000132	0.000936	CcSEcCtD
Haloperidol—Body temperature increased—Dorzolamide—glaucoma	0.000131	0.000932	CcSEcCtD
Haloperidol—Agranulocytosis—Timolol—glaucoma	0.00013	0.000925	CcSEcCtD
Haloperidol—Anxiety—Clonidine—glaucoma	0.00013	0.000924	CcSEcCtD
Haloperidol—Dizziness—Bimatoprost—glaucoma	0.00013	0.000922	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00013	0.000921	CcSEcCtD
Haloperidol—Urticaria—Brinzolamide—glaucoma	0.00013	0.00092	CcSEcCtD
Haloperidol—Feeling abnormal—Pilocarpine—glaucoma	0.000129	0.000918	CcSEcCtD
Haloperidol—Vomiting—Apraclonidine—glaucoma	0.000129	0.000914	CcSEcCtD
Haloperidol—Muscle spasms—Betaxolol—glaucoma	0.000129	0.000912	CcSEcCtD
Haloperidol—Hypersensitivity—Brimonidine—glaucoma	0.000128	0.000909	CcSEcCtD
Haloperidol—Dry mouth—Clonidine—glaucoma	0.000128	0.000907	CcSEcCtD
Haloperidol—Dermatitis—Apraclonidine—glaucoma	0.000128	0.000905	CcSEcCtD
Haloperidol—Headache—Apraclonidine—glaucoma	0.000127	0.0009	CcSEcCtD
Haloperidol—Confusional state—Clonidine—glaucoma	0.000126	0.000897	CcSEcCtD
Haloperidol—Vision blurred—Betaxolol—glaucoma	0.000126	0.000894	CcSEcCtD
Haloperidol—Oedema—Clonidine—glaucoma	0.000125	0.000889	CcSEcCtD
Haloperidol—Tremor—Betaxolol—glaucoma	0.000125	0.000889	CcSEcCtD
Haloperidol—Hallucination—Timolol—glaucoma	0.000125	0.000886	CcSEcCtD
Haloperidol—Body temperature increased—Pilocarpine—glaucoma	0.000124	0.00088	CcSEcCtD
Haloperidol—Diarrhoea—Acetazolamide—glaucoma	0.000124	0.00088	CcSEcCtD
Haloperidol—Rash—Bimatoprost—glaucoma	0.000124	0.000879	CcSEcCtD
Haloperidol—Dermatitis—Bimatoprost—glaucoma	0.000124	0.000878	CcSEcCtD
Haloperidol—Anaemia—Betaxolol—glaucoma	0.000124	0.000877	CcSEcCtD
Haloperidol—Connective tissue disorder—Timolol—glaucoma	0.000123	0.000875	CcSEcCtD
Haloperidol—Pruritus—Brimonidine—glaucoma	0.000123	0.000873	CcSEcCtD
Haloperidol—Headache—Bimatoprost—glaucoma	0.000123	0.000873	CcSEcCtD
Haloperidol—Nervous system disorder—Clonidine—glaucoma	0.000123	0.000872	CcSEcCtD
Haloperidol—Thrombocytopenia—Clonidine—glaucoma	0.000123	0.000871	CcSEcCtD
Haloperidol—Hypersensitivity—Dorzolamide—glaucoma	0.000122	0.000868	CcSEcCtD
Haloperidol—Tachycardia—Clonidine—glaucoma	0.000122	0.000868	CcSEcCtD
Haloperidol—Hypersensitivity—Travoprost—glaucoma	0.000122	0.000864	CcSEcCtD
Haloperidol—Skin disorder—Clonidine—glaucoma	0.000122	0.000864	CcSEcCtD
Haloperidol—Hyperhidrosis—Clonidine—glaucoma	0.000121	0.00086	CcSEcCtD
Haloperidol—Visual impairment—Timolol—glaucoma	0.000121	0.000858	CcSEcCtD
Haloperidol—Nausea—Apraclonidine—glaucoma	0.00012	0.000854	CcSEcCtD
Haloperidol—Hypersensitivity—Brinzolamide—glaucoma	0.00012	0.000854	CcSEcCtD
Haloperidol—Vertigo—Betaxolol—glaucoma	0.00012	0.000852	CcSEcCtD
Haloperidol—Dizziness—Acetazolamide—glaucoma	0.00012	0.00085	CcSEcCtD
Haloperidol—Anorexia—Clonidine—glaucoma	0.00012	0.000848	CcSEcCtD
Haloperidol—Pruritus—Dorzolamide—glaucoma	0.000118	0.000834	CcSEcCtD
Haloperidol—Eye disorder—Timolol—glaucoma	0.000117	0.000832	CcSEcCtD
Haloperidol—Hypotension—Clonidine—glaucoma	0.000117	0.000831	CcSEcCtD
Haloperidol—Pruritus—Travoprost—glaucoma	0.000117	0.00083	CcSEcCtD
Haloperidol—Nausea—Bimatoprost—glaucoma	0.000117	0.000828	CcSEcCtD
Haloperidol—Cardiac disorder—Timolol—glaucoma	0.000116	0.000826	CcSEcCtD
Haloperidol—Hypersensitivity—Pilocarpine—glaucoma	0.000116	0.00082	CcSEcCtD
Haloperidol—Pruritus—Brinzolamide—glaucoma	0.000116	0.00082	CcSEcCtD
Haloperidol—Vomiting—Acetazolamide—glaucoma	0.000115	0.000817	CcSEcCtD
Haloperidol—Dizziness—Brimonidine—glaucoma	0.000115	0.000816	CcSEcCtD
Haloperidol—Angiopathy—Timolol—glaucoma	0.000114	0.000808	CcSEcCtD
Haloperidol—Diarrhoea—Dorzolamide—glaucoma	0.000114	0.000806	CcSEcCtD
Haloperidol—Headache—Acetazolamide—glaucoma	0.000114	0.000805	CcSEcCtD
Haloperidol—Anxiety—Betaxolol—glaucoma	0.000113	0.000805	CcSEcCtD
Haloperidol—Insomnia—Clonidine—glaucoma	0.000113	0.000804	CcSEcCtD
Haloperidol—Immune system disorder—Timolol—glaucoma	0.000113	0.000804	CcSEcCtD
Haloperidol—Diarrhoea—Travoprost—glaucoma	0.000113	0.000803	CcSEcCtD
Haloperidol—Mediastinal disorder—Timolol—glaucoma	0.000113	0.000802	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000113	0.000802	CcSEcCtD
Haloperidol—Dyspnoea—Clonidine—glaucoma	0.000112	0.000793	CcSEcCtD
Haloperidol—Diarrhoea—Brinzolamide—glaucoma	0.000112	0.000793	CcSEcCtD
Haloperidol—Somnolence—Clonidine—glaucoma	0.000111	0.000791	CcSEcCtD
Haloperidol—Dry mouth—Betaxolol—glaucoma	0.000111	0.00079	CcSEcCtD
Haloperidol—Pruritus—Pilocarpine—glaucoma	0.000111	0.000788	CcSEcCtD
Haloperidol—Alopecia—Timolol—glaucoma	0.000111	0.000787	CcSEcCtD
Haloperidol—Confusional state—Betaxolol—glaucoma	0.00011	0.000781	CcSEcCtD
Haloperidol—Mental disorder—Timolol—glaucoma	0.00011	0.00078	CcSEcCtD
Haloperidol—Dizziness—Dorzolamide—glaucoma	0.00011	0.000779	CcSEcCtD
Haloperidol—Rash—Brimonidine—glaucoma	0.00011	0.000778	CcSEcCtD
Haloperidol—Dermatitis—Brimonidine—glaucoma	0.00011	0.000777	CcSEcCtD
Haloperidol—Dizziness—Travoprost—glaucoma	0.000109	0.000776	CcSEcCtD
Haloperidol—Malnutrition—Timolol—glaucoma	0.000109	0.000775	CcSEcCtD
Haloperidol—Oedema—Betaxolol—glaucoma	0.000109	0.000774	CcSEcCtD
Haloperidol—Headache—Brimonidine—glaucoma	0.000109	0.000773	CcSEcCtD
Haloperidol—Decreased appetite—Clonidine—glaucoma	0.000109	0.000773	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Clonidine—glaucoma	0.000108	0.000768	CcSEcCtD
Haloperidol—Dizziness—Brinzolamide—glaucoma	0.000108	0.000766	CcSEcCtD
Haloperidol—Nausea—Acetazolamide—glaucoma	0.000108	0.000764	CcSEcCtD
Haloperidol—Diarrhoea—Pilocarpine—glaucoma	0.000107	0.000762	CcSEcCtD
Haloperidol—Constipation—Clonidine—glaucoma	0.000107	0.00076	CcSEcCtD
Haloperidol—Nervous system disorder—Betaxolol—glaucoma	0.000107	0.000759	CcSEcCtD
Haloperidol—Thrombocytopenia—Betaxolol—glaucoma	0.000107	0.000758	CcSEcCtD
Haloperidol—Tachycardia—Betaxolol—glaucoma	0.000107	0.000756	CcSEcCtD
Haloperidol—Skin disorder—Betaxolol—glaucoma	0.000106	0.000752	CcSEcCtD
Haloperidol—Vomiting—Dorzolamide—glaucoma	0.000106	0.000749	CcSEcCtD
Haloperidol—Hyperhidrosis—Betaxolol—glaucoma	0.000106	0.000748	CcSEcCtD
Haloperidol—Rash—Dorzolamide—glaucoma	0.000105	0.000743	CcSEcCtD
Haloperidol—Dermatitis—Dorzolamide—glaucoma	0.000105	0.000742	CcSEcCtD
Haloperidol—Rash—Travoprost—glaucoma	0.000104	0.00074	CcSEcCtD
Haloperidol—Dermatitis—Travoprost—glaucoma	0.000104	0.000739	CcSEcCtD
Haloperidol—Headache—Dorzolamide—glaucoma	0.000104	0.000738	CcSEcCtD
Haloperidol—Anorexia—Betaxolol—glaucoma	0.000104	0.000738	CcSEcCtD
Haloperidol—Vomiting—Brinzolamide—glaucoma	0.000104	0.000737	CcSEcCtD
Haloperidol—Dizziness—Pilocarpine—glaucoma	0.000104	0.000736	CcSEcCtD
Haloperidol—Headache—Travoprost—glaucoma	0.000104	0.000735	CcSEcCtD
Haloperidol—Nausea—Brimonidine—glaucoma	0.000103	0.000733	CcSEcCtD
Haloperidol—Feeling abnormal—Clonidine—glaucoma	0.000103	0.000733	CcSEcCtD
Haloperidol—Rash—Brinzolamide—glaucoma	0.000103	0.00073	CcSEcCtD
Haloperidol—Vision blurred—Timolol—glaucoma	0.000103	0.00073	CcSEcCtD
Haloperidol—Dermatitis—Brinzolamide—glaucoma	0.000103	0.00073	CcSEcCtD
Haloperidol—Headache—Brinzolamide—glaucoma	0.000102	0.000726	CcSEcCtD
Haloperidol—Hypotension—Betaxolol—glaucoma	0.000102	0.000723	CcSEcCtD
Haloperidol—Vomiting—Pilocarpine—glaucoma	9.98e-05	0.000708	CcSEcCtD
Haloperidol—Urticaria—Clonidine—glaucoma	9.96e-05	0.000706	CcSEcCtD
Haloperidol—Body temperature increased—Clonidine—glaucoma	9.91e-05	0.000703	CcSEcCtD
Haloperidol—Rash—Pilocarpine—glaucoma	9.9e-05	0.000702	CcSEcCtD
Haloperidol—Dermatitis—Pilocarpine—glaucoma	9.89e-05	0.000701	CcSEcCtD
Haloperidol—Insomnia—Betaxolol—glaucoma	9.87e-05	0.0007	CcSEcCtD
Haloperidol—Nausea—Dorzolamide—glaucoma	9.87e-05	0.0007	CcSEcCtD
Haloperidol—Headache—Pilocarpine—glaucoma	9.84e-05	0.000698	CcSEcCtD
Haloperidol—Nausea—Travoprost—glaucoma	9.83e-05	0.000697	CcSEcCtD
Haloperidol—Vertigo—Timolol—glaucoma	9.82e-05	0.000696	CcSEcCtD
Haloperidol—Dyspnoea—Betaxolol—glaucoma	9.73e-05	0.00069	CcSEcCtD
Haloperidol—Nausea—Brinzolamide—glaucoma	9.7e-05	0.000688	CcSEcCtD
Haloperidol—Dyspepsia—Betaxolol—glaucoma	9.61e-05	0.000681	CcSEcCtD
Haloperidol—Decreased appetite—Betaxolol—glaucoma	9.49e-05	0.000673	CcSEcCtD
Haloperidol—Hypertension—Timolol—glaucoma	9.43e-05	0.000669	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Betaxolol—glaucoma	9.42e-05	0.000668	CcSEcCtD
Haloperidol—Constipation—Betaxolol—glaucoma	9.33e-05	0.000662	CcSEcCtD
Haloperidol—Nausea—Pilocarpine—glaucoma	9.33e-05	0.000661	CcSEcCtD
Haloperidol—Anxiety—Timolol—glaucoma	9.27e-05	0.000657	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	9.24e-05	0.000655	CcSEcCtD
Haloperidol—Hypersensitivity—Clonidine—glaucoma	9.24e-05	0.000655	CcSEcCtD
Haloperidol—Dry mouth—Timolol—glaucoma	9.1e-05	0.000645	CcSEcCtD
Haloperidol—Feeling abnormal—Betaxolol—glaucoma	9e-05	0.000638	CcSEcCtD
Haloperidol—Confusional state—Timolol—glaucoma	8.99e-05	0.000638	CcSEcCtD
Haloperidol—Oedema—Timolol—glaucoma	8.92e-05	0.000632	CcSEcCtD
Haloperidol—Anaphylactic shock—Timolol—glaucoma	8.92e-05	0.000632	CcSEcCtD
Haloperidol—Pruritus—Clonidine—glaucoma	8.87e-05	0.000629	CcSEcCtD
Haloperidol—Nervous system disorder—Timolol—glaucoma	8.75e-05	0.00062	CcSEcCtD
Haloperidol—Urticaria—Betaxolol—glaucoma	8.67e-05	0.000615	CcSEcCtD
Haloperidol—Skin disorder—Timolol—glaucoma	8.66e-05	0.000614	CcSEcCtD
Haloperidol—Body temperature increased—Betaxolol—glaucoma	8.63e-05	0.000612	CcSEcCtD
Haloperidol—Hyperhidrosis—Timolol—glaucoma	8.62e-05	0.000611	CcSEcCtD
Haloperidol—Diarrhoea—Clonidine—glaucoma	8.58e-05	0.000608	CcSEcCtD
Haloperidol—Anorexia—Timolol—glaucoma	8.5e-05	0.000603	CcSEcCtD
Haloperidol—Hypotension—Timolol—glaucoma	8.33e-05	0.000591	CcSEcCtD
Haloperidol—Dizziness—Clonidine—glaucoma	8.29e-05	0.000588	CcSEcCtD
Haloperidol—Insomnia—Timolol—glaucoma	8.07e-05	0.000572	CcSEcCtD
Haloperidol—Hypersensitivity—Betaxolol—glaucoma	8.04e-05	0.00057	CcSEcCtD
Haloperidol—Vomiting—Clonidine—glaucoma	7.97e-05	0.000565	CcSEcCtD
Haloperidol—Dyspnoea—Timolol—glaucoma	7.95e-05	0.000564	CcSEcCtD
Haloperidol—Somnolence—Timolol—glaucoma	7.93e-05	0.000562	CcSEcCtD
Haloperidol—Rash—Clonidine—glaucoma	7.91e-05	0.000561	CcSEcCtD
Haloperidol—Dermatitis—Clonidine—glaucoma	7.9e-05	0.00056	CcSEcCtD
Haloperidol—Headache—Clonidine—glaucoma	7.86e-05	0.000557	CcSEcCtD
Haloperidol—Dyspepsia—Timolol—glaucoma	7.85e-05	0.000557	CcSEcCtD
Haloperidol—Decreased appetite—Timolol—glaucoma	7.75e-05	0.00055	CcSEcCtD
Haloperidol—Pruritus—Betaxolol—glaucoma	7.72e-05	0.000548	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Timolol—glaucoma	7.7e-05	0.000546	CcSEcCtD
Haloperidol—Diarrhoea—Betaxolol—glaucoma	7.47e-05	0.00053	CcSEcCtD
Haloperidol—Nausea—Clonidine—glaucoma	7.45e-05	0.000528	CcSEcCtD
Haloperidol—Feeling abnormal—Timolol—glaucoma	7.35e-05	0.000521	CcSEcCtD
Haloperidol—Dizziness—Betaxolol—glaucoma	7.22e-05	0.000512	CcSEcCtD
Haloperidol—Urticaria—Timolol—glaucoma	7.08e-05	0.000502	CcSEcCtD
Haloperidol—Body temperature increased—Timolol—glaucoma	7.05e-05	0.0005	CcSEcCtD
Haloperidol—Vomiting—Betaxolol—glaucoma	6.94e-05	0.000492	CcSEcCtD
Haloperidol—Rash—Betaxolol—glaucoma	6.88e-05	0.000488	CcSEcCtD
Haloperidol—Dermatitis—Betaxolol—glaucoma	6.88e-05	0.000488	CcSEcCtD
Haloperidol—Headache—Betaxolol—glaucoma	6.84e-05	0.000485	CcSEcCtD
Haloperidol—Hypersensitivity—Timolol—glaucoma	6.57e-05	0.000466	CcSEcCtD
Haloperidol—Nausea—Betaxolol—glaucoma	6.48e-05	0.00046	CcSEcCtD
Haloperidol—Pruritus—Timolol—glaucoma	6.31e-05	0.000447	CcSEcCtD
Haloperidol—Diarrhoea—Timolol—glaucoma	6.1e-05	0.000433	CcSEcCtD
Haloperidol—Dizziness—Timolol—glaucoma	5.9e-05	0.000418	CcSEcCtD
Haloperidol—Vomiting—Timolol—glaucoma	5.67e-05	0.000402	CcSEcCtD
Haloperidol—Rash—Timolol—glaucoma	5.62e-05	0.000399	CcSEcCtD
Haloperidol—Dermatitis—Timolol—glaucoma	5.62e-05	0.000398	CcSEcCtD
Haloperidol—Headache—Timolol—glaucoma	5.59e-05	0.000396	CcSEcCtD
Haloperidol—Nausea—Timolol—glaucoma	5.3e-05	0.000376	CcSEcCtD
Haloperidol—HTR2A—Signaling by GPCR—EDN1—glaucoma	8.78e-06	0.000184	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NTRK1—glaucoma	8.77e-06	0.000184	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EDN1—glaucoma	8.76e-06	0.000183	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	8.65e-06	0.000181	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	8.65e-06	0.000181	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—C3—glaucoma	8.58e-06	0.00018	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—C3—glaucoma	8.44e-06	0.000177	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—C3—glaucoma	8.43e-06	0.000176	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GSTM1—glaucoma	8.41e-06	0.000176	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CDKN2B—glaucoma	8.39e-06	0.000176	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NTRK1—glaucoma	8.37e-06	0.000175	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NGFR—glaucoma	8.31e-06	0.000174	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CDKN2B—glaucoma	8.21e-06	0.000172	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NGFR—glaucoma	8.2e-06	0.000172	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CDKN2B—glaucoma	8.08e-06	0.000169	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EDN1—glaucoma	8.05e-06	0.000169	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GSTT1—glaucoma	8.02e-06	0.000168	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—TXN—glaucoma	8e-06	0.000168	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SMO—glaucoma	7.99e-06	0.000167	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NTRK1—glaucoma	7.89e-06	0.000165	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	7.89e-06	0.000165	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EDN1—glaucoma	7.88e-06	0.000165	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SMO—glaucoma	7.86e-06	0.000165	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SMO—glaucoma	7.85e-06	0.000164	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—TXN—glaucoma	7.81e-06	0.000164	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—C3—glaucoma	7.79e-06	0.000163	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NTRK1—glaucoma	7.79e-06	0.000163	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EDN1—glaucoma	7.75e-06	0.000162	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CDKN2B—glaucoma	7.71e-06	0.000162	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—C3—glaucoma	7.67e-06	0.000161	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—C3—glaucoma	7.65e-06	0.00016	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GSTT1—glaucoma	7.58e-06	0.000159	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CA1—glaucoma	7.47e-06	0.000156	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—MTHFR—glaucoma	7.43e-06	0.000156	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EDN1—glaucoma	7.4e-06	0.000155	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NGF—glaucoma	7.39e-06	0.000155	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—TXN—glaucoma	7.36e-06	0.000154	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NTRK2—glaucoma	7.31e-06	0.000153	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.3e-06	0.000153	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—TXN—glaucoma	7.29e-06	0.000153	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CDKN2B—glaucoma	7.27e-06	0.000152	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NGF—glaucoma	7.24e-06	0.000152	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.23e-06	0.000151	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CTSA—glaucoma	7.23e-06	0.000151	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NTRK2—glaucoma	7.19e-06	0.000151	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NTRK2—glaucoma	7.18e-06	0.00015	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CDKN2B—glaucoma	7.18e-06	0.00015	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NGF—glaucoma	7.13e-06	0.000149	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GSTM1—glaucoma	7.07e-06	0.000148	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—C3—glaucoma	7.03e-06	0.000147	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EDN1—glaucoma	6.98e-06	0.000146	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	6.96e-06	0.000146	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—APOE—glaucoma	6.92e-06	0.000145	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EDN1—glaucoma	6.89e-06	0.000144	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—C3—glaucoma	6.88e-06	0.000144	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CAV1—glaucoma	6.85e-06	0.000144	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CA2—glaucoma	6.83e-06	0.000143	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NGF—glaucoma	6.8e-06	0.000142	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—C3—glaucoma	6.77e-06	0.000142	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.66e-06	0.000139	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.59e-06	0.000138	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—APOE—glaucoma	6.54e-06	0.000137	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CAV1—glaucoma	6.48e-06	0.000136	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—C3—glaucoma	6.47e-06	0.000135	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NGF—glaucoma	6.41e-06	0.000134	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—APOE—glaucoma	6.41e-06	0.000134	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CYP1B1—glaucoma	6.39e-06	0.000134	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ABCA1—glaucoma	6.39e-06	0.000134	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CAV1—glaucoma	6.35e-06	0.000133	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NGF—glaucoma	6.33e-06	0.000133	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—APOE—glaucoma	6.31e-06	0.000132	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NGFR—glaucoma	6.27e-06	0.000131	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—MTHFR—glaucoma	6.25e-06	0.000131	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CAV1—glaucoma	6.25e-06	0.000131	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TXN—glaucoma	6.23e-06	0.000131	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GSTT1—glaucoma	6.2e-06	0.00013	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—FN1—glaucoma	6.17e-06	0.000129	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NGFR—glaucoma	6.17e-06	0.000129	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NGFR—glaucoma	6.16e-06	0.000129	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.11e-06	0.000128	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—BAD—glaucoma	6.1e-06	0.000128	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—C3—glaucoma	6.1e-06	0.000128	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GSTT1—glaucoma	6.05e-06	0.000127	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—FN1—glaucoma	6.04e-06	0.000127	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ABCA1—glaucoma	6.04e-06	0.000126	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CYP1B1—glaucoma	6.04e-06	0.000126	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—APOE—glaucoma	6.02e-06	0.000126	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—C3—glaucoma	6.02e-06	0.000126	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—BAD—glaucoma	5.97e-06	0.000125	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CAV1—glaucoma	5.96e-06	0.000125	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NTRK1—glaucoma	5.96e-06	0.000125	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—FN1—glaucoma	5.95e-06	0.000125	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—BAD—glaucoma	5.88e-06	0.000123	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NTRK1—glaucoma	5.86e-06	0.000123	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NTRK1—glaucoma	5.85e-06	0.000123	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—APOE—glaucoma	5.82e-06	0.000122	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CAV1—glaucoma	5.76e-06	0.000121	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GSTT1—glaucoma	5.71e-06	0.000119	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	5.69e-06	0.000119	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—FN1—glaucoma	5.68e-06	0.000119	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—APOE—glaucoma	5.68e-06	0.000119	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GSTT1—glaucoma	5.66e-06	0.000118	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	5.64e-06	0.000118	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CAV1—glaucoma	5.62e-06	0.000118	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—BAD—glaucoma	5.61e-06	0.000117	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—APOE—glaucoma	5.6e-06	0.000117	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CAV1—glaucoma	5.55e-06	0.000116	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CDKN2B—glaucoma	5.49e-06	0.000115	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CDKN2B—glaucoma	5.4e-06	0.000113	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CDKN2B—glaucoma	5.39e-06	0.000113	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FN1—glaucoma	5.35e-06	0.000112	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—BAD—glaucoma	5.29e-06	0.000111	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FN1—glaucoma	5.28e-06	0.000111	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EDN1—glaucoma	5.27e-06	0.00011	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—BAD—glaucoma	5.22e-06	0.000109	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EDN1—glaucoma	5.19e-06	0.000109	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—NOS3—glaucoma	5.18e-06	0.000109	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EDN1—glaucoma	5.17e-06	0.000108	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GSTM1—glaucoma	5.11e-06	0.000107	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5e-06	0.000105	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CYP1B1—glaucoma	4.94e-06	0.000104	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ABCA1—glaucoma	4.94e-06	0.000104	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NOS3—glaucoma	4.9e-06	0.000103	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NGF—glaucoma	4.84e-06	0.000101	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GSTT1—glaucoma	4.83e-06	0.000101	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GSTM1—glaucoma	4.83e-06	0.000101	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ABCA1—glaucoma	4.82e-06	0.000101	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CYP1B1—glaucoma	4.82e-06	0.000101	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TXN—glaucoma	4.81e-06	0.000101	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NOS3—glaucoma	4.8e-06	0.000101	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NGF—glaucoma	4.77e-06	9.98e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NGF—glaucoma	4.75e-06	9.96e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PTGS2—glaucoma	4.74e-06	9.93e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NOS3—glaucoma	4.72e-06	9.89e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—C3—glaucoma	4.6e-06	9.64e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.56e-06	9.55e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ABCA1—glaucoma	4.55e-06	9.52e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CYP1B1—glaucoma	4.55e-06	9.52e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—C3—glaucoma	4.53e-06	9.49e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—C3—glaucoma	4.52e-06	9.47e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—MTHFR—glaucoma	4.52e-06	9.46e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NOS3—glaucoma	4.51e-06	9.44e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CYP1B1—glaucoma	4.51e-06	9.44e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ABCA1—glaucoma	4.51e-06	9.44e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—NOS3—glaucoma	4.36e-06	9.13e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—APOE—glaucoma	4.29e-06	8.98e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—MTHFR—glaucoma	4.27e-06	8.94e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NOS3—glaucoma	4.25e-06	8.91e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CDKN1B—glaucoma	4.25e-06	8.89e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CAV1—glaucoma	4.25e-06	8.89e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—APOE—glaucoma	4.22e-06	8.83e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—APOE—glaucoma	4.21e-06	8.81e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—APOE—glaucoma	4.2e-06	8.81e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NOS3—glaucoma	4.2e-06	8.79e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CAV1—glaucoma	4.18e-06	8.75e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CAV1—glaucoma	4.17e-06	8.73e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CAV1—glaucoma	4.17e-06	8.72e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CDKN1B—glaucoma	4.16e-06	8.71e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CDKN1B—glaucoma	4.09e-06	8.57e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FN1—glaucoma	4.04e-06	8.46e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—BAD—glaucoma	3.99e-06	8.36e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTGS2—glaucoma	3.99e-06	8.35e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FN1—glaucoma	3.98e-06	8.33e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—APOE—glaucoma	3.97e-06	8.32e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FN1—glaucoma	3.97e-06	8.31e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GSTM1—glaucoma	3.95e-06	8.27e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CAV1—glaucoma	3.94e-06	8.24e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MMP9—glaucoma	3.93e-06	8.24e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—BAD—glaucoma	3.93e-06	8.23e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—BAD—glaucoma	3.92e-06	8.21e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CDKN1B—glaucoma	3.91e-06	8.18e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.9e-06	8.16e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GSTM1—glaucoma	3.86e-06	8.08e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MMP9—glaucoma	3.85e-06	8.07e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ABCA1—glaucoma	3.85e-06	8.06e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP1B1—glaucoma	3.85e-06	8.06e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MMP9—glaucoma	3.79e-06	7.94e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTT1—glaucoma	3.73e-06	7.81e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CDKN1B—glaucoma	3.68e-06	7.72e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CDKN1B—glaucoma	3.63e-06	7.61e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GSTM1—glaucoma	3.63e-06	7.61e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MMP9—glaucoma	3.62e-06	7.58e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GSTM1—glaucoma	3.6e-06	7.54e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—glaucoma	3.53e-06	7.4e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MTHFR—glaucoma	3.49e-06	7.31e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—glaucoma	3.46e-06	7.24e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MMP9—glaucoma	3.41e-06	7.15e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MTHFR—glaucoma	3.41e-06	7.14e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—glaucoma	3.4e-06	7.13e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MMP9—glaucoma	3.37e-06	7.05e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOE—glaucoma	3.25e-06	6.81e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—glaucoma	3.25e-06	6.8e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CAV1—glaucoma	3.22e-06	6.75e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—glaucoma	3.21e-06	6.73e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOS3—glaucoma	3.21e-06	6.72e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—glaucoma	3.18e-06	6.67e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOE—glaucoma	3.17e-06	6.64e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOS3—glaucoma	3.16e-06	6.62e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOS3—glaucoma	3.15e-06	6.6e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NOS3—glaucoma	3.15e-06	6.6e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CAV1—glaucoma	3.14e-06	6.58e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GSTM1—glaucoma	3.08e-06	6.45e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—glaucoma	3.06e-06	6.42e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—glaucoma	3.02e-06	6.33e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOE—glaucoma	2.99e-06	6.26e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NOS3—glaucoma	2.98e-06	6.23e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP1B1—glaucoma	2.97e-06	6.22e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCA1—glaucoma	2.97e-06	6.22e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOE—glaucoma	2.96e-06	6.21e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CAV1—glaucoma	2.96e-06	6.2e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CAV1—glaucoma	2.94e-06	6.15e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—glaucoma	2.88e-06	6.03e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CDKN1B—glaucoma	2.78e-06	5.83e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CDKN1B—glaucoma	2.74e-06	5.73e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CDKN1B—glaucoma	2.73e-06	5.72e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—glaucoma	2.72e-06	5.7e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—glaucoma	2.72e-06	5.7e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—glaucoma	2.67e-06	5.59e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—glaucoma	2.61e-06	5.47e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MMP9—glaucoma	2.58e-06	5.4e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—glaucoma	2.57e-06	5.39e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MMP9—glaucoma	2.53e-06	5.31e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOE—glaucoma	2.53e-06	5.3e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MMP9—glaucoma	2.53e-06	5.3e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CAV1—glaucoma	2.51e-06	5.26e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—glaucoma	2.45e-06	5.14e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NOS3—glaucoma	2.44e-06	5.1e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NOS3—glaucoma	2.38e-06	4.98e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTM1—glaucoma	2.38e-06	4.98e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—glaucoma	2.32e-06	4.85e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—glaucoma	2.31e-06	4.84e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—glaucoma	2.28e-06	4.78e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—glaucoma	2.28e-06	4.77e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—glaucoma	2.27e-06	4.76e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NOS3—glaucoma	2.24e-06	4.69e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—glaucoma	2.23e-06	4.66e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NOS3—glaucoma	2.22e-06	4.65e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—glaucoma	2.17e-06	4.55e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—glaucoma	2.1e-06	4.4e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—glaucoma	2.05e-06	4.29e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—glaucoma	2.03e-06	4.25e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOE—glaucoma	1.95e-06	4.09e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CAV1—glaucoma	1.94e-06	4.06e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NOS3—glaucoma	1.9e-06	3.97e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—glaucoma	1.75e-06	3.66e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—glaucoma	1.74e-06	3.63e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—glaucoma	1.72e-06	3.6e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—glaucoma	1.72e-06	3.59e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NOS3—glaucoma	1.46e-06	3.07e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—glaucoma	1.34e-06	2.81e-05	CbGpPWpGaD
